Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Merck
Harvard Business School
Johnson and Johnson
Baxter

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

LEXETTE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Lexette, and when can generic versions of Lexette launch?

Lexette is a drug marketed by Mayne Pharma and is included in one NDA.

The generic ingredient in LEXETTE is halobetasol propionate. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.

US ANDA Litigation and Generic Entry Outlook for Lexette

  Start Trial

A generic version of LEXETTE was approved as halobetasol propionate by FOUGERA PHARMS on January 20th, 2020.

Summary for LEXETTE
Drug patent expirations by year for LEXETTE
Drug Prices for LEXETTE

See drug prices for LEXETTE

Pharmacology for LEXETTE

US Patents and Regulatory Information for LEXETTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma LEXETTE halobetasol propionate AEROSOL, FOAM;TOPICAL 210566-001 May 24, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Merck
Baxter
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.